SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nortran Pharmaceutical -NRT.V -- Ignore unavailable to you. Want to Upgrade?

To: SOROS who wrote (790)5/20/1998 5:36:00 PM
From: Edward W. Richmond  Read Replies (1) | Respond to of 1185
 
Soros, as I pointed out earlier, I have been through this with junior biotechs before and I have been rewarded well, but only if the company has substance. Don't ask me about the times I've been duped. Nortran, in my opinion, has an lot going for it in both product and management. It reminds me of QLT Phototherapeutics when its price dropped to the $7.00 level from a high of about $13.00. QLT closed in the $28.00 range today. I am happy I held on for a fairly long time and didn't listen to the neighsayers(just horsing around ha ha). I've added to my position in Nortran and I am tempted to take profit in other stocks to further increase my holdings.
I suspect that we may yet shake out a few more short term traders before we see a major move.
Regards, Ed



To: SOROS who wrote (790)5/21/1998 1:22:00 AM
From: Mr. Forthright  Respond to of 1185
 
Technical rebound possible. Not based on long term perspective tough. Too many short-term, flaky, self-centered investors involved still.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News